Company Announcements - 2019
CE Mark for Pelvic Organ Prolapse18 April 2019
The PeriCoach system is now CE-Marked to assist in the conservative treatment of Pelvic Organ Prolapse in addition to urinary incontinence.
R&D Tax Incentive Receipt28 March 2019
Analytica is pleased to announce the receipt of $745k from the Australian Taxation Office under the Research and Development incentive related to the financial year to 30th June 2018.
Appendix 4D - Half Year Report27 February 2019
Analytica presents its Appendix 4D - Half year results to 31 December 2018.
Expiry of Unlisted Options13 February 2019
The Company advises that 5 million unlisted options at exercise price $0.0439 expired on 5pm 12 February 2019.
Appendix 4C31 January 2019
Analytica presents its quarterly cash flow report to 31 December 2018.